167
Views
10
CrossRef citations to date
0
Altmetric
Drug Evaluation

Drug evaluation of clevidipine for acute hypertension

, MD, , MD & , MD
Pages 2519-2529 | Published online: 08 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Pantelis A Sarafidis, Panagiotis I Georgianos, Pavlos Malindretos & Vassilios Liakopoulos. (2012) Pharmacological management of hypertensive emergencies and urgencies: focus on newer agents. Expert Opinion on Investigational Drugs 21:8, pages 1089-1106.
Read now
Alma Rivera, Elsa Montoya & Joseph Varon. (2010) Intravenous clevidipine for management of hypertension. Integrated Blood Pressure Control 3, pages 105-111.
Read now
Sergio D Bergese & Erika G Puente. (2010) Clevidipine butyrate: a promising new drug for the management of acute hypertension. Expert Opinion on Pharmacotherapy 11:2, pages 281-295.
Read now

Articles from other publishers (7)

Bo Xu, Zhen Chen & Gaorui Tang. (2021) The Current Role of Clevidipine in the Management of Hypertension. American Journal of Cardiovascular Drugs 22:2, pages 127-139.
Crossref
Hamdy Hassanain, Mohamed Hassona, Erika Puente, Chengwen Sun, Zeinb Abouelnaga, David Tulman & Sergio Bergese. (2013) In Vitro Assessment of Clevidipine Using the Profilin1 Hypertensive Mouse Model. Pharmaceuticals 6:5, pages 623-633.
Crossref
Sudeep Kumar, Tanuj Bhatia & Aditya Kapoor. (2013) Hypertension emergencies and urgencies. Clinical Queries: Nephrology 2:1, pages 1-14.
Crossref
Pantelis A. Sarafidis & George L. Bakris. 2010. Comprehensive Clinical Nephrology. Comprehensive Clinical Nephrology 445 450 .
Kenneth W Kenyon. (2009) New Drug Approvals: Clevidipine: An Ultra Short-Acting Calcium Channel Antagonist for Acute Hypertension. Annals of Pharmacotherapy 43:7-8, pages 1258-1265.
Crossref
Lendita Prlesi & Angela Cheng-Lai. (2009) Clevidipine. Cardiology in Review 17:3, pages 147-152.
Crossref
Shridhar Hegde & Michelle Schmidt. 2009. Annual Reports in Medicinal Chemistry Volume 44. Annual Reports in Medicinal Chemistry Volume 44 577 632 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.